Polymyalgia Rheumatica (PMR) Clinical Trials

7 recruitingLast updated: June 18, 2026

There are 7 actively recruiting polymyalgia rheumatica (pmr) clinical trials across 4 countries. Studies span Phase 3, Phase 4. Top locations include Odense, Denmark, Bonn, North Rhine-Westphalia, Germany, Aarhus, Denmark. Updated daily from ClinicalTrials.gov.


Polymyalgia Rheumatica (PMR) Trials at a Glance

7 actively recruiting trials for polymyalgia rheumatica (pmr) are listed on ClinicalTrialsFinder across 6 cities in 4 countries. The largest study group is Phase 3 with 1 trial, with the heaviest enrollment activity in Odense, Bonn, and Aarhus. Lead sponsors running polymyalgia rheumatica (pmr) studies include University of Bonn, Centre Hospitalier Universitaire Dijon, and Kresten Krarup Keller.

Browse polymyalgia rheumatica (pmr) trials by phase

Treatments under study

About Polymyalgia Rheumatica (PMR) Clinical Trials

Looking for clinical trials for Polymyalgia Rheumatica (PMR)? There are currently 7 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Polymyalgia Rheumatica (PMR) trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Polymyalgia Rheumatica (PMR) clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 17 of 7 trials

Recruiting
Phase 3

Justification And Evaluation of Baricitinib Plus Corticosteroids Versus corticosteroiDs Alone in pOlymyalgia RhEumatica

Polymyalgia Rheumatica (PMR)
University Hospital, Brest140 enrolled22 locationsNCT07279688
Recruiting
Phase 4

Hydrocortisone and Placebo in Patients With Symptoms of Adrenal Insufficiency After Cessation of Glucocorticoid Treatment

Adrenal InsufficiencyGiant Cell Arteritis (GCA)Polymyalgia Rheumatica (PMR)
Marianne Andersen100 enrolled3 locationsNCT05193396
Recruiting

Using Novel Imaging to Rethink Diagnostic and Treatment Strategies for Polymyalgia Rheumatica

Polymyalgia Rheumatica (PMR)
Kresten Krarup Keller149 enrolled7 locationsNCT07010484
Recruiting

Pilot Study to evaluateThrombomodulin to Rule Out Giant Cell Arteritis (GCA) in Polymyalgia Rheumatica (PMR) Patients. (THROPIQ)

Giant Cell Arteritis (GCA)Polymyalgia Rheumatica (PMR)
Centre Hospitalier Universitaire Dijon78 enrolled1 locationNCT06609668
Recruiting

Clinical Assessment for Rheumatologic Disease - Research and Advancement in Safety and Efficacy

Psoriatic Arthritis (PsA)Rheumatoid Arthritis (RA)Systemic Sclerosis (SSc)+10 more
University of Bonn120 enrolled1 locationNCT07150000
Recruiting

AYLo - AutoimmunitY and Loss of y

Asthma BronchialeCOPDSarcoidosis+10 more
University of Bonn500 enrolled1 locationNCT06696027
Recruiting

Predictive Factors for Treatment Response in Patients With Newly-diagnosed Polymyalgia Rheumatica and Giant Cell Arteritis

Giant Cell Arteritis (GCA)Polymyalgia Rheumatica (PMR)
University Hospital, Basel, Switzerland30 enrolled1 locationNCT05479448